Prevalence and Clinical Implications of HPV Infection in Male IBD Patients
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age18-79
SponsorFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
About this trial
The study aims at describing the prevalence of Human Papillomavirus (HPV) infection in anal and oral samples of men with Inflammatory Bowel Disease (IBD) and detecting risk factors for the infection.
Eligibility criteria
Qualifiers
Diagnosed Crohn's disease or ulcerative colitis (at least 3 months before enrollment)
Male
Age from 18 to 79 years
Disqualifiers
Unclassified Inflammatory Bowel Disease
Diarrhea (> 3 bowel movements/day) with rectal bleeding at enrollment
Prior full proctectomy
Inability to collect the biological samples
Trial design
Treatments tested in this trial
- Anal pap smear and oral swab for cytology and HPV testing
Treatment groups
384 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov